Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

HIV prevalence in young people and children living on the streets, Kenya.

Braitstein P, Ayuku D, DeLong A, Makori D, Sang E, Tarus C, Kamanda A, Shah P, Apondi E, Wachira J.

Bull World Health Organ. 2019 Jan 1;97(1):33-41. doi: 10.2471/BLT.18.210211. Epub 2018 Nov 6.

2.

Deep learning in biomedicine.

Wainberg M, Merico D, Delong A, Frey BJ.

Nat Biotechnol. 2018 Oct;36(9):829-838. doi: 10.1038/nbt.4233. Epub 2018 Sep 6.

PMID:
30188539
3.

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.

Kantor R, DeLong A, Schreier L, Reitsma M, Kemboi E, Orido M, Obonge S, Boinett R, Rono M, Emonyi W, Brooks K, Coetzer M, Buziba N, Hogan J, Diero L.

AIDS. 2018 Nov 13;32(17):2485-2496. doi: 10.1097/QAD.0000000000001964.

PMID:
30134290
4.

Evaluation of the robustness of polarization attraction for 10.7-GBaud NRZ-BPSK after long-haul 100-GHz DWDM transmission.

DeLong A, Astar W, Cannon BM, Carter GM.

Opt Express. 2018 Jun 25;26(13):16639-16669. doi: 10.1364/OE.26.016639.

PMID:
30119490
5.

Accumulated pre-switch resistance to more recently introduced one-pill-once-a-day antiretroviral regimens impacts HIV-1 virologic outcome.

Reece R, Delong A, Matthew D, Tashima K, Kantor R.

J Clin Virol. 2018 Aug;105:11-17. doi: 10.1016/j.jcv.2018.05.008. Epub 2018 May 21.

PMID:
29807234
6.

High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Saravanan S, Gomathi S, Delong A, Kausalya B, Sivamalar S, Poongulali S, Brooks K, Kumarasamy N, Balakrishnan P, Solomon SS, Cu-Uvin S, Kantor R.

J Antimicrob Chemother. 2018 Aug 1;73(8):2152-2161. doi: 10.1093/jac/dky154.

PMID:
29800305
7.

Inference of the human polyadenylation code.

Leung MKK, Delong A, Frey BJ.

Bioinformatics. 2018 Sep 1;34(17):2889-2898. doi: 10.1093/bioinformatics/bty211.

8.

Recurrent Enlarging Mesenteric Desmoid Tumor following Remote Surgical Resection.

Hapgood C, DeLong A.

Case Rep Radiol. 2017;2017:2312617. doi: 10.1155/2017/2312617. Epub 2017 Dec 18.

9.

Polarization attraction of 10-Gb/s NRZ-BPSK signal in a highly nonlinear fiber.

DeLong A, Astar W, Mahmood T, Carter GM.

Opt Express. 2017 Oct 16;25(21):25625-25636. doi: 10.1364/OE.25.025625.

PMID:
29041227
10.

Positive selection analysis highlights key positions in plant PP2A regulatory subunits.

Booker MA, DeLong A.

Plant Signal Behav. 2017 Aug 3;12(8):e1347245. doi: 10.1080/15592324.2017.1347245. Epub 2017 Jul 10.

11.

Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study.

Vedanthan R, Kamano JH, Lee H, Andama B, Bloomfield GS, DeLong AK, Edelman D, Finkelstein EA, Hogan JW, Horowitz CR, Manyara S, Menya D, Naanyu V, Pastakia SD, Valente TW, Wanyonyi CC, Fuster V.

Am Heart J. 2017 Jun;188:175-185. doi: 10.1016/j.ahj.2017.03.012. Epub 2017 Mar 23.

12.

The Orthopedic Trauma Symposium: improving care of orthopedic injuries in Haiti.

Normore R, Greene H, DeLong A, Furey A.

Can J Surg. 2017 Aug;60(4):228-235.

13.

Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution.

Liu T, Hogan JW, Daniels MJ, Coetzer M, Xu Y, Bove G, DeLong AK, Ledingham L, Orido M, Diero L, Kantor R.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):580-587. doi: 10.1097/QAI.0000000000001424.

14.

Atypical Protein Phosphatase 2A Gene Families Do Not Expand via Paleopolyploidization.

Booker MA, DeLong A.

Plant Physiol. 2017 Feb;173(2):1283-1300. doi: 10.1104/pp.16.01768. Epub 2016 Dec 29.

15.

Local Submodularization for Binary Pairwise Energies.

Gorelick L, Boykov Y, Veksler O, Ayed IB, Delong A.

IEEE Trans Pattern Anal Mach Intell. 2017 Oct;39(10):1985-1999. doi: 10.1109/TPAMI.2016.2630686. Epub 2016 Nov 18.

PMID:
27875215
16.
17.

Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 Subtypes.

Huang A, Hogan JW, Luo X, DeLong A, Saravanan S, Wu Y, Sirivichayakul S, Kumarasamy N, Zhang F, Phanuphak P, Diero L, Buziba N, Istrail S, Katzenstein DA, Kantor R.

Open Forum Infect Dis. 2015 Nov 3;3(2):ofv158. doi: 10.1093/ofid/ofv158. eCollection 2016 Apr.

18.

Predictors of Change in Functional Health Status in Adults with Repaired Tetralogy of Fallot.

Lu JC, Yu S, Lowery R, Sagi J, Delong AC, Agarwal PP, Mahani MG, Dorfman AL.

Pediatr Cardiol. 2016 Oct;37(7):1334-9. doi: 10.1007/s00246-016-1439-y. Epub 2016 Jul 2.

PMID:
27371413
19.

Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.

Brooks K, Diero L, DeLong A, Balamane M, Reitsma M, Kemboi E, Orido M, Emonyi W, Coetzer M, Hogan J, Kantor R.

J Int AIDS Soc. 2016 May 25;19(1):20798. doi: 10.7448/IAS.19.1.20798. eCollection 2016.

20.

Misclassification of Antiretroviral Treatment Failure Using WHO 2006 and 2010/2013 Immunologic Criteria in HIV-Infected Children and Adolescents in Western Kenya.

Dufort EM, DeLong AK, Mann M, Nyandiko WM, Ayaya SO, Hogan JW, Kantor R.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):285-288. doi: 10.1093/jpids/piw018.

21.

Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya.

Bloomfield GS, DeLong AK, Akwanalo CO, Hogan JW, Carter EJ, Aswa DF, Binanay C, Koech M, Kimaiyo S, Velazquez EJ.

Glob Heart. 2016 Mar;11(1):97-107. doi: 10.1016/j.gheart.2015.12.014.

22.

A Hospital-Based Interdisciplinary Model for Increasing Nurses' Engagement in Legislative Advocacy.

Waddell A, Audette K, DeLong A, Brostoff M.

Policy Polit Nurs Pract. 2016 Feb;17(1):15-23. doi: 10.1177/1527154416630638. Epub 2016 Feb 15.

PMID:
26880725
23.

HemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing.

Brooks K, DeLong A, Balamane M, Schreier L, Orido M, Chepkenja M, Kemboi E, D'Antuono M, Chan PA, Emonyi W, Diero L, Coetzer M, Kantor R.

J Clin Microbiol. 2016 Jan;54(1):223-5. doi: 10.1128/JCM.02853-15. Epub 2015 Nov 11.

24.

Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men.

Chan PA, Hogan JW, Huang A, DeLong A, Salemi M, Mayer KH, Kantor R.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):428-35. doi: 10.1097/QAI.0000000000000786.

25.

Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning.

Alipanahi B, Delong A, Weirauch MT, Frey BJ.

Nat Biotechnol. 2015 Aug;33(8):831-8. doi: 10.1038/nbt.3300. Epub 2015 Jul 27.

PMID:
26213851
26.

Identification of Open Stomata1-Interacting Proteins Reveals Interactions with Sucrose Non-fermenting1-Related Protein Kinases2 and with Type 2A Protein Phosphatases That Function in Abscisic Acid Responses.

Waadt R, Manalansan B, Rauniyar N, Munemasa S, Booker MA, Brandt B, Waadt C, Nusinow DA, Kay SA, Kunz HH, Schumacher K, DeLong A, Yates JR 3rd, Schroeder JI.

Plant Physiol. 2015 Sep;169(1):760-79. doi: 10.1104/pp.15.00575. Epub 2015 Jul 14.

27.

Producing the Ethylene Signal: Regulation and Diversification of Ethylene Biosynthetic Enzymes.

Booker MA, DeLong A.

Plant Physiol. 2015 Sep;169(1):42-50. doi: 10.1104/pp.15.00672. Epub 2015 Jul 1. Review.

28.
29.

Factors associated with isolated right heart failure in women: a pilot study from western Kenya.

Lagat DK, DeLong AK, Wellenius GA, Carter EJ, Bloomfield GS, Velazquez EJ, Hogan J, Kimaiyo S, Sherman CB.

Glob Heart. 2014 Jun;9(2):249-54. doi: 10.1016/j.gheart.2014.04.003.

30.

Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island.

Rogo T, DeLong AK, Chan P, Kantor R.

Clin Infect Dis. 2015 May 1;60(9):1426-35. doi: 10.1093/cid/civ058. Epub 2015 Jan 30.

31.

Transmitted HIV drug resistance at the Thai Red Cross anonymous clinic in Bangkok: results from three consecutive years of annual surveillance.

Sirivichayakul S, Kantor R, DeLong AK, Wongkunya R, Mekprasan S, Ruxrungtham K, Sohn AH, Phanuphak P.

J Antimicrob Chemother. 2015 Apr;70(4):1146-9. doi: 10.1093/jac/dku499. Epub 2014 Dec 18.

32.

HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Kantor R, DeLong A, Balamane M, Schreier L, Lloyd RM Jr, Injera W, Kamle L, Mambo F, Muyonga S, Katzenstein D, Hogan J, Buziba N, Diero L.

J Int AIDS Soc. 2014 Nov 18;17:19262. doi: 10.7448/IAS.17.1.19262. eCollection 2014.

33.

Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial.

Vedanthan R, Kamano JH, Naanyu V, Delong AK, Were MC, Finkelstein EA, Menya D, Akwanalo CO, Bloomfield GS, Binanay CA, Velazquez EJ, Hogan JW, Horowitz CR, Inui TS, Kimaiyo S, Fuster V.

Trials. 2014 Apr 27;15:143. doi: 10.1186/1745-6215-15-143.

34.

Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island.

Chan PA, Reitsma MB, DeLong A, Boucek B, Nunn A, Salemi M, Kantor R.

Infect Genet Evol. 2014 Dec;28:358-66. doi: 10.1016/j.meegid.2014.03.027. Epub 2014 Apr 8.

35.

Potential benefits of retreatment highlight the need for additional Lyme disease research.

DeLong AK, Blossom B, Maloney E, Phillips SE.

Am J Med. 2014 Feb;127(2):e9-e10. doi: 10.1016/j.amjmed.2013.08.028. No abstract available.

PMID:
24462019
36.

The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic.

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH.

AIDS Patient Care STDS. 2014 Jan;28(1):4-9. doi: 10.1089/apc.2013.0130.

37.

Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure.

Mann M, Diero L, Kemboi E, Mambo F, Rono M, Injera W, Delong A, Schreier L, Kaloustian KW, Sidle J, Buziba N, Kantor R.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):220-224. doi: 10.1097/QAI.0b013e31829ec485. Erratum in: J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):323. Kaloustian, Kara W [corrected to Wools-Kaloustian, Kara].

38.

Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S.

J Womens Health (Larchmt). 2013 Apr;22(4):330-8. doi: 10.1089/jwh.2012.3849. Epub 2013 Mar 26.

39.

Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines.

Coetzer M, Westley B, Delong A, Tray C, Sophearin D, Nerrienet E, Schreier L, Kantor R.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):985-92. doi: 10.1089/AID.2013.0025. Epub 2013 Apr 27.

40.

The effects of amplitude normalization and EMG targets on cVEMP interaural amplitude asymmetry.

McCaslin DL, Jacobson GP, Hatton K, Fowler AP, DeLong AP.

Ear Hear. 2013 Jul-Aug;34(4):482-90. doi: 10.1097/AUD.0b013e31827ad792.

PMID:
23361360
41.

Outpatient parenteral antibiotic therapy for Lyme borreliosis: a 'real world' view.

Stricker RB, Delong AK, Johnson L.

QJM. 2013 Feb;106(2):201-3. doi: 10.1093/qjmed/hcs227. Epub 2012 Dec 6. No abstract available.

PMID:
23220702
42.

QColors: an algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads.

Huang A, Kantor R, DeLong A, Schreier L, Istrail S.

In Silico Biol. 2011-2012;11(5-6):193-201. doi: 10.3233/ISB-2012-0454.

43.

Evaluation of longitudinal clinical outcomes and adherence to care among HIV-infected refugees.

Winston SE, Montague BT, Lopez MJ, Delong A, Lemarchand C, Bedoya A, Gillani FS, Beckwith CG.

J Int Assoc Provid AIDS Care. 2013 May-Jun;12(3):202-7. doi: 10.1177/1545109712459680. Epub 2012 Sep 28.

44.

Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials.

Delong AK, Blossom B, Maloney EL, Phillips SE.

Contemp Clin Trials. 2012 Nov;33(6):1132-42. doi: 10.1016/j.cct.2012.08.009. Epub 2012 Aug 19. Review.

PMID:
22922244
45.

Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.

Huang A, Hogan JW, Istrail S, Delong A, Katzenstein DA, Kantor R.

Future Virol. 2012 May;7(5):505-517.

46.

Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children.

Westley BP, DeLong AK, Tray CS, Sophearin D, Dufort EM, Nerrienet E, Schreier L, Harwell JI, Kantor R.

Clin Infect Dis. 2012 Aug;55(3):432-40. doi: 10.1093/cid/cis433. Epub 2012 Apr 26.

47.

Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.

Nijhawan AE, Delong AK, Chapman S, Rana A, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:868526. doi: 10.1155/2012/868526. Epub 2012 Feb 28.

48.

Arabidopsis thaliana histone deacetylase 14 (HDA14) is an α-tubulin deacetylase that associates with PP2A and enriches in the microtubule fraction with the putative histone acetyltransferase ELP3.

Tran HT, Nimick M, Uhrig RG, Templeton G, Morrice N, Gourlay R, DeLong A, Moorhead GB.

Plant J. 2012 Jul;71(2):263-72. doi: 10.1111/j.1365-313X.2012.04984.x. Epub 2012 May 2.

49.

The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.

Nijhawan AE, DeLong AK, Celentano DD, Klein RS, Sobel JD, Jamieson DJ, Cu-Uvin S.

Sex Transm Dis. 2011 Dec;38(12):1094-100. doi: 10.1097/OLQ.0b013e31822ea147.

50.

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.

Stricker RB, Delong AK, Green CL, Savely VR, Chamallas SN, Johnson L.

Int J Gen Med. 2011;4:639-46. doi: 10.2147/IJGM.S23829. Epub 2011 Sep 6.

Supplemental Content

Loading ...
Support Center